Predicting tumor treatment outcomes through genetic variability prediction of tumor cells

Posted on : 2015-08-18, Iore Journal of Bioinformatics and Computational Biology

Researchers from Ohio state university have come out with a new scoring method they developed called MATH (mutant-allele tumor heterogeneity) to measure the genetic variability among cancer cells. Patients with higher genetic variability of cancer cells depicts lower survival rate upon treatment than those with lower genetic variability. Higher variability points out to the fact that cancer cells are adapted to a particular chemotherapy and might out give the expected results. Using MATH scores doctors could easily predict cancer progression and cancer treatment outcomes.

« Previous
Latest From Blog
  • Predicting tumor treatment outcomes through genetic...Read More
  • Diversified Crop Production – A solution to globa...Read More
  • Spices prolonged life span ...Read More
  • Stressed childhood could lead to depression in adul...Read More
  • Gene Therapy Treatment for Obesity...Read More
  • Gut Microbe and obesity- an unseen link...Read More
  • Increased probability of Burkitt's lymphoma due to m...Read More
  • Surviving El Nino- an attempt...Read More
  • Diabetic complications and Vitamin intake ...Read More
  • Bacteria diagnosing cancer cells ...Read More